Solid-state analysis for pharmaceuticals: Pathways to feasible and meaningful analysis

The solid state of matter is the preferred starting point for designing a pharmaceutical product. This is driven by both patient preferences and the relative ease of supplying a solid pharmaceutical product with desired quality and performance. Solid form diversity is increasingly prevalent as a crucial element in designing these products, which underpins the importance of solid-state analytical methods. This paper provides a critical analysis of challenges related to solid-state analytics, as well as considerations and suggestions for feasible and meaningful pharmaceutical analysis.

Automated summary

The solid state of matter is the preferred starting point for designing pharmaceutical products, and the importance of solid-state analytical methods is emphasized. This paper critically analyzes the challenges related to solid-state analytics and provides considerations and suggestions for feasible and meaningful pharmaceutical analysis.